Table 6. Days to first postoperative follow-up.
Postdischarge days to follow-up | Readmitted prior to follow-up | ||||||
---|---|---|---|---|---|---|---|
Reason for readmission | n | Surgeon a | Endocrinologist b | Surgeon a | Endocrinologist b | ||
Mean ± SD | Median (IQR) | Mean ± SD | Median (IQR) | n ( n %) | n ( n %) | ||
Not readmitted | 352 | 8.3 ± 7.2 | 6 (5– 8) | 22.7 ± 13.8 | 21 (13–30) | N/A | N/A |
Readmitted | 57 | 11.4 ± 11.1 | 8 (4– 16) | 23.3 ± 11.5 | 20.5 (16.5– 27.5) | 29 (50.9%) | 45 (79.0%) |
Cerebrospinal fluid leak | 14 | 15.1 ± 15.6 | 11 (5– 21) | 28.2 ± 8.3 | 27 (26–29) | 8 (57.1%) | 10 (71.4%) |
Epistaxis | 11 | 7.9 ± 5.8 | 6.5 (4– 8) | 13 ± 9.9 | 13 (6– 20) | 5 (45.5%) | 11 (100%) |
Hyponatremia | 17 | 12.8 ± 10.5 | 10 (5– 21) | 22.6 ± 10.7 | 23 (15–27) | 11 (64.7%) | 15 (88.2%) |
Hypernatremia | 5 | 8.3 ± 3.5 | 8 (5– 12) | 38 ± 22.6 | 38 (22–54) | 2 (40%) | 5 (100%) |
Adrenal insufficiency | 5 | 13.3 ± 9.4 | 13.5 (6– 20.5) | 25.5 ± 3.5 | 25.5 (23–28) | 4 (80%) | 5 (100%) |
Pain/headache | 16 | 14.2 ± 16.7 | 8 (5–21) | 18.1 ± 6.8 | 17 (15–26) | 9 (56.3%) | 14 (87.5%) |
Abbreviations: IQR, interquartile range; N/A, not applicable; SD, standard deviation.
Follow-up with either a neurosurgeon or otolaryngologist.
Follow-up with either institutional or community/private endocrinology.
Note: Values are presented as number (%) unless otherwise indicated.